What is Evolutionary Genomics Gross-Profit-to-Asset %?
Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Evolutionary Genomics's annualizedGross Profit for the quarter that ended in Dec. 2022 was $0.00 Mil.
Evolutionary Genomics's average Total Assets over the quarter that ended in Dec. 2022 was $2.52 Mil. Therefore, Evolutionary Genomics's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2022 was 0.00%.
Evolutionary Genomics Gross-Profit-to-Asset % Historical Data
The historical data trend for Evolutionary Genomics's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Evolutionary Genomics's Gross-Profit-to-Asset %
For the Biotechnology subindustry, Evolutionary Genomics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolutionary Genomics's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Evolutionary Genomics's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Evolutionary Genomics's Gross-Profit-to-Asset % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2022) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Evolutionary Genomics Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Evolutionary Genomics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Evolutionary Genomics (Evolutionary Genomics) Business Description
Evolutionary Genomics Inc is involved in the development of a technology platform, the Adapted Traits Platform (ATP), to identify commercially valuable genes that control important traits in animals and plants. It uses the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. The company's platform identifies key genes that have changed successfully to impart new or improved traits. Its primary source of revenue had been contract services revenue for research performed by it on behalf of other commercial entities and grant income received from governmental agencies, industry associations and grant-making foundations for research performed.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FNAM has been successfully added to your 